Identification of candidate prostate cancer biomarkers in prostate needle biopsy specimens using proteomic analysis

Although serum prostate specific antigen (PSA) is a well‐established diagnostic tool for prostate cancer (PCa) detection, the definitive diagnosis of PCa is based on the information contained in prostate needle biopsy (PNBX) specimens. To define the proteomic features of PNBX specimens to identify candidate biomarkers for PCa, PNBX specimens from patients with PCa or benign prostatic hyperplasia (BPH) were subjected to comparative proteomic analysis. 2‐DE revealed that 52 protein spots exhibited statistically significantly changes among PCa and BPH groups. Interesting spots were identified by MALDI‐TOF‐MS/MS. The 2 most notable groups of proteins identified included latent androgen receptor coregulators [FLNA(7–15) and FKBP4] and enzymes involved in mitochondrial fatty acid β‐oxidation (DCI and ECHS1). An imbalance in the expression of peroxiredoxin subtypes was noted in PCa specimens. Furthermore, different post‐translationally modified isoforms of HSP27 and HSP70.1 were identified. Importantly, changes in FLNA(7–15), FKBP4, and PRDX4 expression were confirmed by immunoblot analyses. Our results suggest that a proteomics‐based approach is useful for developing a more complete picture of the protein profile of PNBX specimen. The proteins identified by this approach may be useful molecular targets for PCa diagnostics and therapeutics. © 2007 Wiley‐Liss, Inc.

[1]  J. Hiltunen,et al.  β‐Oxidation of unsaturated fatty acids in humans Isoforms of Δ3, Δ2‐enoyl‐CoA isomerase , 1993 .

[2]  W. Ha,et al.  The differential proteome profile of stomach cancer: identification of the biomarker candidates. , 2004, Oncology research.

[3]  Sang Won Kang,et al.  Peroxiredoxins in breast carcinoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[4]  Z. A. Wood,et al.  Structure, mechanism and regulation of peroxiredoxins. , 2003, Trends in biochemical sciences.

[5]  E. Petricoin,et al.  Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines , 2000, Electrophoresis.

[6]  L. Butterfield,et al.  From cytoprotection to tumor suppression: the multifactorial role of peroxiredoxins. , 1999, Antioxidants & redox signaling.

[7]  E. Lam,et al.  Androgens target prohibitin to regulate proliferation of prostate cancer cells , 2004, Oncogene.

[8]  Chawnshang Chang,et al.  Androgen Receptor Coregulators in Prostate Cancer , 2004, Clinical Cancer Research.

[9]  W. Isaacs,et al.  Peroxisomal branched chain fatty acid β‐oxidation pathway is upregulated in prostate cancer , 2005, The Prostate.

[10]  John A. Taylor,et al.  Increasing the number of core samples taken at prostate needle biopsy enhances the detection of clinically significant prostate cancer. , 2002, Urology.

[11]  L. Ramagli.  Quantifying protein in 2-D PAGE solubilization buffers. , 1999, Methods in molecular biology.

[12]  C. Walsh,et al.  The many faces of filamin: A versatile molecular scaffold for cell motility and signalling , 2004, Nature Cell Biology.

[13]  R. Wait,et al.  A modified silver staining protocol for visualization of proteins compatible with matrix‐assisted laser desorption/ionization and electrospray ionization‐ mass spectrometry , 2000, Electrophoresis.

[14]  W. Isaacs,et al.  Improved biomarkers for prostate cancer: a definite need. , 2004, Journal of the National Cancer Institute.

[15]  Eun Sug Park,et al.  Role of Peroxiredoxins in Regulating Intracellular Hydrogen Peroxide and Hydrogen Peroxide-induced Apoptosis in Thyroid Cells* , 2000, The Journal of Biological Chemistry.

[16]  T. Holman,et al.  Evidence for downregulation of calcium signaling proteins in advanced mouse adenocarcinoma , 2005, The Prostate.

[17]  Joyce Cheung-Flynn,et al.  Physiological role for the cochaperone FKBP52 in androgen receptor signaling. , 2005, Molecular endocrinology.

[18]  A. Jemal,et al.  Cancer Statistics, 2006 , 2006, CA: a cancer journal for clinicians.

[19]  N. Bander,et al.  Prostate-specific membrane antigen association with filamin A modulates its internalization and NAALADase activity. , 2003, Cancer research.

[20]  W. Isaacs,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Pathological and Molecular Aspects of Prostate Cancer Prostate Cancer Ii , 2022 .

[21]  F. España,et al.  Prostate–Specific Antigen Complexed to α1–Antichymotrypsin in the Early Detection of Prostate Cancer , 2000, European Urology.

[22]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[23]  K. Meehan,et al.  Proteomic analysis of normal and malignant prostate tissue to identify novel proteins lost in cancer , 2002, The Prostate.

[24]  Wun-Jae Kim,et al.  Enhanced expression of peroxiredoxin I and VI correlates with development, recurrence and progression of human bladder cancer. , 2006, The Journal of urology.

[25]  Y. Soini,et al.  Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma , 2002, The Journal of pathology.

[26]  S. Robertson.  Filamin A: phenotypic diversity. , 2005, Current opinion in genetics & development.

[27]  Matthias Kretzler,et al.  Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: a gene expression analysis on total and microdissected prostate tissue. , 2002, The American journal of pathology.

[28]  P. Binz,et al.  Heat shock proteins in human cancer , 2000, Electrophoresis.

[29]  N. Iizuka,et al.  Proteomic profiling of proteins decreased in hepatocellular carcinoma from patients infected with hepatitis C virus , 2004, Proteomics.

[30]  E. Yong,et al.  Filamin-A fragment localizes to the nucleus to regulate androgen receptor and coactivator functions , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Z. Hall.  Cancer , 1906, The Hospital.

[32]  Magnus Hellström,et al.  Proteomic analysis of protein expression in prostate cancer. , 2005, Analytical and quantitative cytology and histology.

[33]  S. Ferdinandusse,et al.  Subcellular localization and physiological role of alpha-methylacyl-CoA racemase. , 2000, Journal of lipid research.

[34]  S. Woolf.  Screening for prostate cancer with prostate-specific antigen. An examination of the evidence. , 1995, The New England journal of medicine.

[35]  Ximing J. Yang,et al.  P504S/&agr;-Methylacyl-CoA Racemase: A Useful Marker for Diagnosis of Small Foci of Prostatic Carcinoma on Needle Biopsy , 2002, The American journal of surgical pathology.

[36]  E. Brown,et al.  Filamin-A Binds to the Carboxyl-terminal Tail of the Calcium-sensing Receptor, an Interaction That Participates in CaR-mediated Activation of Mitogen-activated Protein Kinase* , 2001, The Journal of Biological Chemistry.

[37]  J. Hiltunen,et al.  Beta-oxidation of unsaturated fatty acids in humans. Isoforms of delta 3, delta 2-enoyl-CoA isomerase. , 1993, FEBS letters.

[38]  V. Neuhoff,et al.  Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G‐250 and R‐250 , 1988, Electrophoresis.

[39]  M. Gleave,et al.  Heat Shock Protein 27 Increases after Androgen Ablation and Plays a Cytoprotective Role in Hormone-Refractory Prostate Cancer , 2004, Cancer Research.

[40]  J. Hartwig,et al.  Cytoskeletal Protein ABP-280 Directs the Intracellular Trafficking of Furin and Modulates Proprotein Processing in the Endocytic Pathway , 1997, The Journal of cell biology.

[41]  J. J. Edwards,et al.  Proteins of human urine. II. Identification by two-dimensional electrophoresis of a new candidate marker for prostatic cancer. , 1982, Clinical chemistry.

[42]  M. Varma,et al.  Diagnostic utility of immunohistochemistry in morphologically difficult prostate cancer: review of current literature , 2005, Histopathology.

[43]  M. Ljungman,et al.  Hsp90-binding Immunophilins Link p53 to Dynein During p53 Transport to the Nucleus* , 2004, Journal of Biological Chemistry.

[44]  J. Neoptolemos,et al.  Heat shock protein expression independently predicts clinical outcome in prostate cancer. , 2000, Cancer research.

[45]  M. L. Le Beau,et al.  Human mitochondrial enoyl-CoA hydratase gene (ECHS1): structural organization and assignment to chromosome 10q26.2-q26.3. , 1997, Genomics.